CN1066945C - Chinese drug Mingmudan pill for improving eyesight and its producing method - Google Patents
Chinese drug Mingmudan pill for improving eyesight and its producing method Download PDFInfo
- Publication number
- CN1066945C CN1066945C CN96119647A CN96119647A CN1066945C CN 1066945 C CN1066945 C CN 1066945C CN 96119647 A CN96119647 A CN 96119647A CN 96119647 A CN96119647 A CN 96119647A CN 1066945 C CN1066945 C CN 1066945C
- Authority
- CN
- China
- Prior art keywords
- radix
- dry
- fructus
- powder
- mingmudan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a traditional Chinese medicine Mingmudan for improving eyesight, and a making method thereof. In the method, 24 Chinese herbal medicines of ginseng, hairy antler, human placenta, desertliving cistanche, etc. which have the functions of invigorating vital function, nourishing the kidney, benefiting the liver, tranquillizing, stabilizing the mind, dredging channels, opening the orifices and replenishing vital essence to improve eyesight, are sieved, processed, pulverized and encapsulated at the environment of asepsis, and the traditional Chinese medicine Mingmudan is obtained. The present invention has simple production method, can improve microcirculatory and blood circulation of ocular region, replenish and strengthen nutrition, has the advantages of less dosage, obvious effect, no toxic side or effect and high consolidation rate after cure, has good therapeutic effect on shortsightedness, hyperopia, strabismus, weak sight, scattered light, cataract and glaucoma, and particularly has optimal efficiency of hyperopia.
Description
The present invention relates to a kind of medicine for the treatment of various common ophthalmics, is the middle medicament of making eye bright of feedstock production with the Chinese herbal medicine specifically, the invention still further relates to the production method of this medicine.
Myopia, hypermetropia, stravismus, amblyopia, astigmatism, senile cataract, glaucoma are to influence people's work and study, life, even the able-bodied common ophthalmic of serious harm people, in recent years, along with the fast development of industry and the serious environmental of therefore bringing are day by day polluted, the sickness rate of various ophthalmics is more and more higher, the method of treatment is more at present, as operation (laser surgery that comprises traditional operation and began in recent years to occur); Various myoporthosis instrument; Medicine injection etc.Traditional operation mainly be treatment senile surgical effect is more obvious from cataract and glaucoma, but success rate is not high, the therapeutic process patient is also painful, and controls the furuncle narrow range; Laser surgery is mainly used in treatment myopia, and is respond well, but the equipment requirements height, the treatment cost costliness is difficult for promoting the use of; Therapeutic domain is also narrow; Various therapeutic instrument for shortsightedness are also used stimulating acupoints such as heat, electricity, light nothing more than, reaching therapeutic purposes, and one pair of treatment glasses dozens of yuan at least, hundreds of at most units, curative effect is not obvious again, mainly plays health-care effect, does not reach good curative effect, and it is low to keep consolidating rate; The medicine injection treatment mainly is a Western medicine, and certain curative effect is arranged, and life-time service easily develops immunity to drugs, and the effect of paying is also big.
In recent years the Chinese medicine that some treatment myopia also occurred, as " the ginseng and pilose antler short sight rehabilitation sheet " that produce in Jilin, price is expensive, and curative effect is not remarkable.
The object of the present invention is to provide a kind ofly have that preparation is simple, price is low, consumption is little, short treating period, instant effect, nontoxic pair of effect, consolidate the rate height, be difficult for make eye bright agent and the production method thereof that recur.
The objective of the invention is based on the traditional Chinese medical science various common ophthalmic pathogeny and Therapeutic Principle, on the secret prescription handed down in the family from generation to generation basis, through studying for a long period of time, with reference to the modern medicine pharmacology, filter out tonifying Qi and lifting yang, the nourishing kidney the liver benefiting, tranquilizing the mind, hold concurrently with promotion ideas-straightening, 24 flavor Chinese herbal medicine of replenishing vital essence to improve eyesight are raw material, make all easily pure Chinese medicine system of taking of carrying with traditional method, this medical instrument has than the effect of strong extension blood capillary, increase regional blood flow, microcirculation improvement supplements the nutrients, and has stronger releasing acetylcholine and the guinea pig in vitro smooth muscle spasm effect due to the barium chloride simultaneously, and can improve the ocular blood circulation, have additional nutrients, blood circulation promoting and blood stasis dispelling reaches eye and gets the then bright purpose of blood.
The present invention makes (consumption is a weight portion) by following component
Radix Ginseng 5-10 part Cornu Cervi Pantotrichum 1-30 part Placenta Hominis 1-3 part Herba Cistanches 6-12 part
Fructus Lycii 6-12 part Semen Cuscutae 6-15 part Fructus Leonuri 5-15 part Fructus Schisandrae Chinensis 3-10 part
Fructus Ligustri Lucidi 10-15 part Rhizoma Acori Graminei 3-10 part Radix Polygalae 3-10 part Rhizoma Cimicifugae 3-6 part
Radix Astragali 10-15 part Poria 10-15 part Radix Bupleuri 5-10 part Rhizoma Atractylodis Macrocephalae 5-15 part
Flos Carthami 3-10 part Radix Rehmanniae 10-15 part Radix Salviae Miltiorrhizae 10-15 part Radix Asparagi 6-12 part
Concha Haliotidis 10-15 part Flos Chrysanthemi 3-10 part Herba Dendrobii 10-20 part Tong Fructus Tribuli 6-15 part
Above-mentioned each component is made medicine production method of the present invention is: at first, handle described raw material stand-by as follows:
(1) Radix Ginseng: section; (2) Cornu Cervi Pantotrichum: grind into powder; (3) Placenta Hominis: clean, dry, grind into powder; (4) Semen Cuscutae, Herba Cistanches: dry; (5) Fructus Lycii, Flos Carthami and the Radix Rehmanniae: dry in the shade; (6) Fructus Leonuri, Rhizoma Acori Graminei, the Radix Astragali, Fructus Schisandrae Chinensis, Radix Polygalae, Flos Chrysanthemi and Tong Fructus Tribuli: dry; (7) Fructus Ligustri Lucidi: dry, cook, be ground into planar; (8) Rhizoma Cimicifugae, the Rhizoma Atractylodis Macrocephalae: dry section; (9) Poria: dry section; (10) Radix Bupleuri: dry cutting, fry with vinegar; (11) Radix Salviae Miltiorrhizae: dry section, steam with wine; (12) Radix Asparagi: selenium is done, and steams with wine; (13) Concha Haliotidis: selenium is dried to be smashed; (14) Herba Dendrobii: cutting; Secondly, with sheet, the whole just raw material pulverize separately that above-mentioned processing cooks, cross 100 order copper and sieve into fine powder; It is smalls that the raw material that is ground into the end is also crossed 100 order shaft screens, with above-mentioned whole powder components by described mixed evenly after, made required powder in sterilization treatment 15-30 minute, the oral capsule of at last powder that makes being packed under aseptic condition No. 0 is made the Mingmudan pill for improving eyesight capsule of 0.5g * 1.
An important feature of the present invention is to contain abundant nutrition in the medicament, comprise rich vegetable protein matter, animal proteinum, vitamins c, the plain B of little life, the plain E of little life and some trace element, can effectively improve the whole and local physiological function of human body, look purpose thereby reach to make eye bright to increase.
The clinical use result of the present invention shows that following advantage is arranged
1, to select the pure natural Chinese herbal medicine for use be raw material in the present invention, nontoxic pair of effect, and curative effect is fast, and consumption is little, price is low.
2, the present invention can be mixed with medicine 1,2, No. 3, can adopt the different model medicine according to all ages and classes, different characteristic of disease, can be widely used in ophthalmics such as treatment myopia, hypermetropia, stravismus, amblyopia, astigmatism, cataract, glaucoma, especially to treat near-sighted best results, total effects reaches more than 90%, and is difficult for recurrence.
3, cooperate my another invention: walnut shell glasses eyesight improving liquid is stifling, the oral administration and externally combination, and therapeutic effect is more remarkable.
In order to show that further the present invention to treating the curative effect of several frequently seen ophthalmics such as myopia, hypermetropia, itemizes some clinical datas and case below.
Among the 10180 routine patients, male 6050 examples, women 4130 examples are wherein suffered from myopia, astigmatic, the age is in 3102 examples in 5-18 year, 19-30 year 1928 examples; 1112 examples of suffering from hypermetropia, amblyopia, stravismus; Cataract 938 examples; Glaucoma 854 examples; Medical history is 812 examples below 3 years, 3-10 726 examples, 708 examples more than 10 years.
According to different patients, the different state of an illness, adopt No. 1,2,3, the medicine of different proportionings respectively, oral drugs, a twice-daily, each 0.5g, 30 days is a course of treatment, cooperates the treatment of eye partial fumigating, after vision restoration is normal, consolidates one course of treatment of multiple medicine.
Observation of curative effect is:
1, recovery from illness: treat and return to 1.0 above person's 8599 examples 1 course of treatment.
2, produce effects: treat 1-2 the course of treatment, capable 1140 examples of vision rising 6-8.
3, effective: as to treat 3-5 the course of treatment, capable 331 examples of vision rising 4-6.
4, invalid: treat 5 courses of treatment, vision restoration is no more than 4 passerbys, 110 examples.
Sum up above-mentioned clinical case, total effective rate reaches 98%, is example with myopia, proves that myopia is light more, and curative effect is good more, and recovery from illness easily.
Model case is introduced:
1, Liu Chunyang, the man, 12 years old, Luohe City faced family members institute of clever county service company of coal office, right vision is 0.05 during first visit, left eye 0.15 is worn mirror-300D, and first, right vision 0.4 course of treatment, left eye 0.6, second the course of treatment right vision reach 0.8, left eye after 1.0, the three courses of treatment binocular vision all reach 1.5.
2, Wang Ke, man, 18 years old, family is in Kaifeng united reaper factory, first visit in 90 years, the readme binocular vision descended 6 years, the acid of normal sense eye, ophthalmalgia, see that object is smudgy, right left vision is respectively 0.1,0.2, and the outer emmetropia optical fundus pathological changes that do not note abnormalities is diagnosed as expansionary high myopia, all reaching 1.5,1994 years further consultation visions through 2 course of therapy binocular visions still is 1.5.
3, Wang Zhen, the man, 11 years old, father and mother suffered from amblyopia in the work of Kaifeng various household supplies company, first visit in July, 91, far away: right eye 0.3, left eye 0.4; Closely: right eye 0.25, left eye 0.3, through two course of therapy, hyperopia and myopia all reach 1.2, three years does not have recurrence subsequently.
4, Wang Hongbin, man, 59 years old, the people is imitated in the Luoyang City, Henan, and main suit's eye blurring of vision has cloud shade two and half, the inspection eyes are looked dumb outward, the liquefaction of vitreous muddiness, and cornea is crooked uneven, the intraocular pressure height, left vision 0.01, right eye 0.02, be diagnosed as cataract,, cooperate the eye fumigation treatment through three course of therapy, the cloud shade disappears at the moment, and left vision reaches 0.8, and right eye reaches 1.0.
5, Li Jing, man, 47 years old, Beijing's 8511 mailbox, 42 branch mailboxes, the main suit looks thing has black speck keeping off 3 years, checks retinitis pigmentosa, the macula lutea dysphonia, photoreaction is blunt, vitreous opacity liquefaction, cornea is crooked uneven, right vision 0.15, left vision 0.12, be diagnosed as cataract, glaucoma,, cooperate the eye fumigation treatment through four courses of treatment of Drug therapy, right vision reaches 0.7, and left eye reaches 0.6, glaucoma, cataract clinical symptom disappearance.
Embodiment:
One, Radix Ginseng 5kg Cornu Cervi Pantotrichum 1kg Placenta Hominis 1kg Herba Cistanches 6kg
Fructus Lycii 6kg Semen Cuscutae 6kg Fructus Leonuri 5kg Fructus Schisandrae Chinensis 3kg
Fructus Ligustri Lucidi 10kg Rhizoma Acori Graminei 3kg Radix Polygalae 1kg Rhizoma Cimicifugae 3kg
Radix Astragali 10kg Poria 10kg Radix Bupleuri 5kg Rhizoma Atractylodis Macrocephalae 5kg
Flos Carthami 1kg Radix Rehmanniae 10kg Radix Salviae Miltiorrhizae 10kg Radix Asparagi 6kg
Concha Haliotidis 10kg Flos Chrysanthemi 3kg Herba Dendrobii 10kg Tong Fructus Tribuli 6kg
With above-mentioned ready raw material Radix Ginseng section; Semen Cuscutae, Herba Cistanches dry, and fry with salt; Fructus Lycii, Flos Carthami and the Radix Rehmanniae dry in the shade; Fructus Leonuri, Rhizoma Acori Graminei, the Radix Astragali, Fructus Schisandrae Chinensis, Radix Polygalae, Flos Chrysanthemi, Tong Fructus Tribuli are dried; Rhizoma Cimicifugae, the Rhizoma Atractylodis Macrocephalae dry section; Poria dries section; Radix Bupleuri dries cutting, fries with vinegar; Radix Salviae Miltiorrhizae dries, cuts into slices, and steams with wine; Radix Asparagi dries, and steams with wine; Concha Haliotidis dries to be smashed; The Herba Dendrobii cutting with the above-mentioned raw materials pulverize separately, is crossed 100 order copper and is sieved into fine powder; Cornu Cervi Pantotrichum is ground into the end crosses 100 order shaft screens, 100 order copper sieve was ground in the Placenta Hominis oven dry into powder, Fructus Ligustri Lucidi dries, cooks, be ground into planarly, cross 100 order copper sieve, the powder that all raw materials are made mixes at last, stir, make 15 minutes sterilization processing, the oral capsule of under aseptic condition, packing into No. 0, the agent capsules that makes eye bright of making 0.5g * 1 gets final product.
Two, Radix Ginseng 8kg Cornu Cervi Pantotrichum 10kg Placenta Hominis 2kg Herba Cistanches 8kg
Fructus Lycii 8kg Semen Cuscutae 10kg Fructus Leonuri 10kg Fructus Schisandrae Chinensis 6kg
Fructus Ligustri Lucidi 12kg Rhizoma Acori Graminei 6kg Radix Polygalae 6kg Rhizoma Cimicifugae 5kg
Radix Astragali 10kg Poria 10kg Radix Bupleuri 5kg Rhizoma Atractylodis Macrocephalae 10kg
Flos Carthami 6kg Radix Rehmanniae 10kg Radix Salviae Miltiorrhizae 10kg Radix Asparagi 6kg
Concha Haliotidis 10kg Flos Chrysanthemi 6kg Herba Dendrobii 10kg Tong Fructus Tribuli 6kg
The raw material of said ratio can be made the agent that makes eye bright by embodiment one described production method.
Three, Radix Ginseng 9kg Cornu Cervi Pantotrichum 15kg Placenta Hominis 3kg Herba Cistanches 9kg
Fructus Lycii 9kg Semen Cuscutae 14kg Fructus Leonuri 15kg Fructus Schisandrae Chinensis 9kg
Fructus Ligustri Lucidi 13kg Rhizoma Acori Graminei 8kg Radix Polygalae 7kg Rhizoma Cimicifugae 5kg
Radix Astragali 10kg Poria 13kg Radix Bupleuri 8kg Rhizoma Atractylodis Macrocephalae 12kg
Flos Carthami 7kg Radix Rehmanniae 13kg Radix Salviae Miltiorrhizae 13kg Radix Asparagi 12kg
Concha Haliotidis 10kg Flos Chrysanthemi 6kg Herba Dendrobii 10kg Tong Fructus Tribuli 8kg
The raw material of said ratio can be made the agent that makes eye bright by embodiment one described production method.
Four, Radix Ginseng 10kg Cornu Cervi Pantotrichum 30kg Placenta Hominis 3kg Herba Cistanches 12kg
Fructus Lycii 12kg Semen Cuscutae 15kg Fructus Leonuri 15kg Fructus Schisandrae Chinensis 10kg
Fructus Ligustri Lucidi 15kg Rhizoma Acori Graminei 10kg Radix Polygalae 10kg Rhizoma Cimicifugae 6kg
Radix Astragali 15kg Poria 15kg Radix Bupleuri 10kg Rhizoma Atractylodis Macrocephalae 15kg
Flos Carthami 10kg Radix Rehmanniae 15kg Radix Salviae Miltiorrhizae 15kg Radix Asparagi 12kg
Concha Haliotidis 15kg Flos Chrysanthemi 10kg Herba Dendrobii 20kg Tong Fructus Tribuli 15kg
Production method is with embodiment one production method.
Embodiment one, two described proportioning medicines cure mainly myopia, hypermetropia; Embodiment three described medicines cure mainly hypermetropia, amblyopia, stravismus; Embodiment four described medicines cure mainly retinopathy such as cataract, glaucoma.
Claims (4)
1, a kind of Chinese medicine Mingmudan pill for improving eyesight is characterized in that the medicament that it is made up of the following weight proportion raw material
Radix Ginseng 5-10 part Cornu Cervi Pantotrichum 1-30 part Placenta Hominis 1-3 part Herba Cistanches 6-12 part
Fructus Lycii 6-12 part Semen Cuscutae 6-15 part Fructus Leonuri 5-15 part Fructus Schisandrae Chinensis 3-10 part
Fructus Ligustri Lucidi 10-15 part Rhizoma Acori Graminei 3-10 part Radix Polygalae 3-10 part Rhizoma Cimicifugae 3-6 part
Radix Astragali 10-15 part Poria 10-15 part Radix Bupleuri 5-10 part Rhizoma Atractylodis Macrocephalae 5-15 part
Flos Carthami 3-10 part Radix Rehmanniae 10-15 part Radix Salviae Miltiorrhizae 10-15 part Radix Asparagi 6-12 part
Concha Haliotidis 10-15 part Flos Chrysanthemi 3-10 part Herba Dendrobii 10-20 part Tong Fructus Tribuli 6-15 part.
2, the middle medicament that makes eye bright according to claim 1 is characterized in that said medicament is a powder.
3, a kind of production method of producing medicament in as claimed in claim 1 the making eye bright is characterized in that handling described raw material stand-by as follows:
(1) Radix Ginseng: section; (2) Cornu Cervi Pantotrichum: grind into powder; (3) Placenta Hominis: clean, dry, grind into powder; (4) Semen Cuscutae, Herba Cistanches: dry; (5) Fructus Lycii, Flos Carthami and the Radix Rehmanniae: dry in the shade; (6) Fructus Leonuri, Rhizoma Acori Graminei, the Radix Astragali, Fructus Schisandrae Chinensis, Radix Polygalae, Flos Chrysanthemi and Tong Fructus Tribuli: dry; (7) Fructus Ligustri Lucidi: dry, cook, be ground into planar; (8) Rhizoma Cimicifugae, the Rhizoma Atractylodis Macrocephalae: dry section; (9) Poria: dry section; (10) Radix Bupleuri: dry cutting, fry with vinegar; (11) Radix Salviae Miltiorrhizae: dry section, steam with wine; (12) Radix Asparagi: dry, steam with wine; (13) Concha Haliotidis: dry and smash; (14) Herba Dendrobii: cutting; Secondly, with sheet material, the whole timber raw material pulverize separately that above-mentioned processing cooks, cross 100 order copper and sieve into fine powder; It is smalls that the raw material that is ground into the end is also crossed 100 order shaft screens, will above-mentioned whole powder components by described mixed even after, made required powder in sterilization treatment 15-30 minute.
4, the production method of medicament in according to claim 3 the making eye bright is characterized in that the powder that the makes O oral capsule of packing into, makes the Mingmudan pill for improving eyesight capsule of 0.5g * 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96119647A CN1066945C (en) | 1996-10-07 | 1996-10-07 | Chinese drug Mingmudan pill for improving eyesight and its producing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96119647A CN1066945C (en) | 1996-10-07 | 1996-10-07 | Chinese drug Mingmudan pill for improving eyesight and its producing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1178682A CN1178682A (en) | 1998-04-15 |
CN1066945C true CN1066945C (en) | 2001-06-13 |
Family
ID=5125886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96119647A Expired - Fee Related CN1066945C (en) | 1996-10-07 | 1996-10-07 | Chinese drug Mingmudan pill for improving eyesight and its producing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1066945C (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1080568C (en) * | 1999-04-02 | 2002-03-13 | 冯朝甫 | Myopia treating medicine |
CN1086137C (en) * | 1999-11-04 | 2002-06-12 | 张瑞安 | Chinese patent medicine for curing senile cataract |
CN100358552C (en) * | 2005-03-24 | 2008-01-02 | 夏云复 | Medicine for treating amblyopia and its preparing method |
CN101433589B (en) * | 2008-12-12 | 2011-04-20 | 丁春华 | Oral Chinese medicine decoction for treating primary enuresis symptoms of children |
CN103099976A (en) * | 2013-01-11 | 2013-05-15 | 管丽丽 | Medicament patch for treating monocular asthenopia |
CN103211969B (en) * | 2013-03-25 | 2015-02-04 | 张新英 | Traditional Chinese medicine for treatment of myopia |
CN103784831A (en) * | 2014-01-15 | 2014-05-14 | 章玲 | Chinese herbal medicine formula for treating glaucoma and preparation method thereof |
CN103830531A (en) * | 2014-03-12 | 2014-06-04 | 逄增容 | Traditional Chinese medicine for treating presbyopia and preparation method thereof |
CN103961491A (en) * | 2014-05-26 | 2014-08-06 | 济南伟传信息技术有限公司 | Traditional Chinese medicine for treating amblyopia |
CN103961492A (en) * | 2014-05-26 | 2014-08-06 | 济南伟传信息技术有限公司 | Traditional Chinese medicine for treating glaucoma |
CN104095011B (en) * | 2014-07-07 | 2016-06-08 | 龚俊豪 | A kind of improve eyesight protect a biscuit |
CN104524000B (en) * | 2015-01-21 | 2018-04-20 | 安徽新华学院 | It is a kind of to improve improving eyesight rapid-released droppills of visual fatigue and preparation method thereof rapidly |
CN108815389A (en) * | 2018-08-16 | 2018-11-16 | 贵州苗之源苗药中药饮片有限公司 | A kind of Chinese medicine composition to nourish the liver to improve visual acuity |
CN108815390A (en) * | 2018-08-16 | 2018-11-16 | 贵州苗之源苗药中药饮片有限公司 | A kind of Chinese medicine composition and preparation method thereof improving eyesight |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056242A (en) * | 1990-05-07 | 1991-11-20 | 陈江辉 | Consolidate the compound method of near-sighted refinery liquor |
CN1107054A (en) * | 1994-09-02 | 1995-08-23 | 覃刚 | Oral medicine for curing vision |
-
1996
- 1996-10-07 CN CN96119647A patent/CN1066945C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056242A (en) * | 1990-05-07 | 1991-11-20 | 陈江辉 | Consolidate the compound method of near-sighted refinery liquor |
CN1107054A (en) * | 1994-09-02 | 1995-08-23 | 覃刚 | Oral medicine for curing vision |
Non-Patent Citations (3)
Title |
---|
山东中医杂志 2095.1.31 治障明目冲剂治疗未成熟期老年性白内障127例 * |
山东中医杂志 2095.1.31 治障明目冲剂治疗未成熟期老年性白内障127例;山西中医 2089.6.30 俞正非中西医结合治疗视神经炎 * |
山西中医 2089.6.30 俞正非中西医结合治疗视神经炎 * |
Also Published As
Publication number | Publication date |
---|---|
CN1178682A (en) | 1998-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101648004B (en) | Medicinal composition for treating eye diseases and application thereof | |
CN1066945C (en) | Chinese drug Mingmudan pill for improving eyesight and its producing method | |
CN1085792A (en) | Treat bathomorphic liniment and preparation method thereof | |
CN1772194A (en) | Chinese herbal medicine prepn for strengthening kidney-Yang | |
CN102631558A (en) | Medicament for treating eye disease and preparation method of medicament | |
CN1907410A (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
CN101037651A (en) | Lucidum mushroom health wine and production method thereof | |
CN108310298A (en) | It is a kind of that there is the Chinese medicine composition and preparation method for alleviating asthenopia, prevention myopia | |
CN104971304A (en) | Xerophthalmia treatment medicine | |
CN1121866C (en) | Chinese medicine for treating man's sexual disfunction and its preparing process | |
CN111558031A (en) | Pure plant multifunctional eye special nutrient solution and preparation method thereof | |
CN103720857A (en) | Traditional Chinese medicinal preparation for treating fundus macular oedema lesion | |
CN1160091C (en) | Medicine for treating ophthalmopathy | |
CN1231244C (en) | Health foods for tonification, being sturdy and postponing senility | |
CN104474509A (en) | Medicine patch for conditioning eye refraction and preparation method of medicine patch | |
CN1256128C (en) | Eye disease treating medicine | |
CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
CN1323595A (en) | Composite medicine for glaucoma | |
CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
CN110269895A (en) | A kind of visual rehabilitation Chinese medicine composition containing fresh Chinese medicine and preparation method thereof, preparation | |
CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
CN111557983A (en) | Chinese medicinal preparation for improving eyesight | |
CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
CN114617939B (en) | Traditional Chinese medicine preparation for treating ischemic cerebral apoplexy | |
CN115444903A (en) | Application of rehabilitation eyesight oral liquid in preparation of eyesight improving medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |